222

CHA VACCINE RESEARCH INSTITUTE

No trades
See on Supercharts

261780 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

CHA Vaccine Research Institute Co., Ltd. operates as a research-oriented biotechnology company. The firm involves in research and development of vaccine products targeting infectious disease as well as chronic disease. It specializes in proprietary vaccine adjuvant L-pampo and recombinant antigen development platform. The company was founded by Hong Mo Moon on June 13, 2000 and is headquartered in Seongnam-si, South Korea.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

261780 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company